Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA lifts clinical hold on phase I NHL study of PPI-2458

June 25, 2004

Good safety profile reported for AP-23573 in patients with refractory tumors

June 25, 2004

New European approval for Herceptin

June 25, 2004

Metabolic conversion of anticancer agent SD-2007 to apicidin in rats

June 25, 2004

Bevacizumab demonstrates substantial clinical activity

June 25, 2004

Panitumumab demonstrates encouraging antitumor activity

June 25, 2004

Broad antitumor activity reported for Veglin in vivo

June 25, 2004

Therapeutic benefits of AVR-118 in cachectic AIDS and cancer patients

June 23, 2004

New Akt kinase inhibitors emerge from Merck R&D

June 22, 2004

First randomized trial to confirm Her1/EGFR inhibitor prolongs survival in NSCLC after chemotherapy

June 22, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...